Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$1.12 - $1.57 $25,756 - $36,105
-22,997 Reduced 20.47%
89,324 $132,000
Q4 2023

Feb 14, 2024

BUY
$0.72 - $1.56 $18,816 - $40,769
26,134 Added 30.32%
112,321 $162,000
Q3 2023

Nov 14, 2023

BUY
$1.07 - $1.39 $22,176 - $28,809
20,726 Added 31.66%
86,187 $93,000
Q2 2023

Aug 14, 2023

BUY
$1.12 - $1.82 $52,640 - $85,540
47,000 Added 254.59%
65,461 $84,000
Q1 2023

May 12, 2023

SELL
$1.25 - $2.0 $4,623 - $7,398
-3,699 Reduced 16.69%
18,461 $24,000
Q4 2022

Feb 14, 2023

BUY
$0.67 - $11.9 $14,847 - $263,704
22,160 New
22,160 $33,000
Q2 2022

Aug 15, 2022

SELL
$0.67 - $3.19 $1,646 - $7,841
-2,458 Reduced 23.56%
7,975 $9,000
Q1 2022

May 13, 2022

BUY
$2.22 - $3.45 $3,196 - $4,968
1,440 Added 16.01%
10,433 $31,000
Q4 2021

Feb 11, 2022

BUY
$2.36 - $3.57 $11,802 - $17,853
5,001 Added 125.28%
8,993 $24,000
Q3 2021

Feb 11, 2022

BUY
$3.5 - $4.5 $7,840 - $10,080
2,240 Added 127.85%
3,992 $14,000
Q2 2021

Feb 11, 2022

BUY
$3.09 - $4.54 $5,413 - $7,954
1,752 New
1,752 $8,000

Others Institutions Holding RIGL

About RIGEL PHARMACEUTICALS INC


  • Ticker RIGL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 172,836,000
  • Market Cap $2.96B
  • Description
  • Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is ...
More about RIGL
Track This Portfolio

Track State Of Wyoming Portfolio

Follow State Of Wyoming and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wyoming with notifications on news.